MAZE
Maze Therapeutics, Inc. · Healthcare
President, R&D & CMO Harold Bernstein sold $270K of Maze Therapeutics, Inc.
Sold$270,111
$26.24Price
10,295Shares
−51%Stake
What MAZE did after the filing
- The stock from Tue, Sep 8 open, $25.76
- +1.1%
- S&P 500, same days
- +0.3%
13 of 30 trading days so far, to the Sep 25 close.
Traded Wed, Sep 2. Filed Fri, Sep 4, 4:22 PM ET, after the close. Returns use the Sep 8 open and the Sep 25 close. Not investment advice.